PubRank

J Einspahr

Author PubWeight™ 13.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Measurement of chemopreventive efficacy in skin biopsies. Anal Quant Cytol Histol 2001 1.25
2 Dose de-escalation chemoprevention trial of alpha-difluoromethylornithine in patients with colon polyps. J Natl Cancer Inst 1994 1.23
3 Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas. Cancer Res 1999 1.12
4 Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa. J Natl Cancer Inst 1999 1.05
5 Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase? J Cell Biochem Suppl 1995 1.05
6 Expression in normal human tissues of five nucleotide excision repair genes measured simultaneously by multiplex reverse transcription-polymerase chain reaction. Cancer Epidemiol Biomarkers Prev 1999 1.02
7 Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics. Gastroenterology 2001 1.00
8 Measurement of prostaglandin E2 in rectal mucosa in human subjects: a method study. Cancer Epidemiol Biomarkers Prev 1995 0.89
9 Effects of dietary wheat bran fiber on rectal epithelial cell proliferation in patients with resection for colorectal cancers. J Natl Cancer Inst 1990 0.87
10 The effect of wheat bran fiber and calcium supplementation on rectal mucosal proliferation rates in patients with resected adenomatous colorectal polyps. Cancer Epidemiol Biomarkers Prev 1997 0.83
11 Experimental dacarbazine antitumor activity and skin toxicity in relation to light exposure and pharmacologic antidotes. Cancer Treat Rep 1987 0.81
12 Effect of dipyridamole on fluorodeoxyuridine cytotoxicity in vitro and in cancer patients. Cancer Chemother Pharmacol 1989 0.77
13 New antitumor agents containing the anthracene nucleus. J Med Chem 1987 0.77
14 Validation of proliferation indices as surrogate endpoint biomarkers. J Cell Biochem Suppl 1994 0.76
15 Pharmacologic pitfalls in the human tumor clonogenic assay. Recent Results Cancer Res 1984 0.75
16 Reproducibility of the measurement of colonic proliferation using bromodeoxyuridine across laboratories. Cancer Epidemiol Biomarkers Prev 1996 0.75
17 In vitro cytotoxicity against fresh human tumors and P388 leukemia predicts the differential in vivo activity of a series of anthracene anticancer drugs. Anticancer Drugs 1991 0.75